There was a trend towards reduced median hepcidin-25 levels in participants with polycystic ovary syndrome (n = 27) compared with weight-matched control subjects (n = 16); however, this did not reach statistical significance. This evidence concerns the gene HAMP and polycystic ovary syndrome.